Actinic Keratosis

SEATTLE , WASHINGTON, UNITED STATES, January 3, 2022 /EINPresswire.com/ -- Global Actinic Keratosis Market

An actinic keratosis is a thin, rough, dry patch on your skin which develops over years of direct sunlight exposure. It is most often found on the surface of the face, ears, lips, forearms, chest or back but can develop on virtually any part of the body. Also sometimes referred to as a solar keratoi, an actinic keratosis usually grows slowly and generally only shows up in older individuals over 40 years of age. In its more advanced stage, it can cause darkening, wrinkling and thickening of the skin, along with a raised discoloration of the skin, called a solar lentigo. An actinic keratosis can be a very chronic condition and it's important to make sure that you know what to look for so that you can get it treated and you don't just have a few dark spots on your skin.

There are two main causes of actinic keratosis - UV radiation and excessive sweating. When you are exposed to sun-ultraviolet rays, your skin becomes damaged and starts to shed dead cells and replace them with new ones. This damage causes the top layer of skin to become thicker than the bottom layer and the new skin starts to protrude from the damaged area. This can happen both on the top layer of skin, which is called the epidermis, and in the deeper layers of skin called the dermis. The spots that appear may be red, purplish, thickened or flat.

𝐓𝐨 𝐆𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐇𝐞𝐫𝐞 @ https://www.coherentmarketinsights.com/insight/request-pdf/1006

Recent Developments:

Major players operating the global actinic keratosis market are focused on approval and launch of new products to expand their product portfolio. For instance, in December 2020, Almirall, S.A. received the U.S. Food and Drug Administration approval for its Klisyri (tirbanibulin) for the topical treatment of actinic keratosis of the face or scalp.

Global Actinic Keratosis Market: Drivers

High prevalence of skin cancer is expected to propel growth of the global actinic keratosis market over the forecast period. Cutaneous squamous cell carcinoma is a skin cancer. The condition develops in the squamous cells that make up the middle and outer layers of the skin. According to one estimate, about 5.4 million basal and squamous cell skin cancers are diagnosed each year in the U.S.

Moreover, high prevalence of actinic keratosis is also expected to aid in growth of the market. For instance, actinic keratosis is the second most common diagnosis made by dermatologists with an estimated 5.2 million U.S. population, which visits physician for AK annually, amounting approximately US$ 920 million for the physician visit and treatment, according to the National Institute of Health, 2015.

Global Actinic Keratosis Market: Opportunities

Availability of affordable mobile applications for detection of skin cancer is expected to offer lucrative growth opportunities for players in the global actinic keratosis market. For instance, Helfie.ai, an app developed by Australia-based entrepreneurs Nick Chang and Matthew Jones, enables users to take a photo of a mole or skin spot using their mobile. The app reportedly checks for skin cancer within minutes for just US$ 3.

𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/1006

Market Trends:

Increasing prevalence of melanoma is expected to propel growth of the global actinic keratosis market over the forecast period. For instance, according to Globocan 2018, there were 144,000 new cases / year in Europe and the disease resulted in 27,000 deaths / year in the region.

Global Actinic Keratosis Market: Restraints

Lack of medical awareness about the skin condition, available treatments, and delayed diagnosis are expected to limit growth of the global actinic keratosis market.

Global Actinic Keratosis Market: Competitive Landscape

Major players operating the global actinic keratosis market include, Aqua Pharmaceuticals, LLC, Apotex, DUSA Pharmaceuticals, Inc., Galderma SA, LEO Laboratories, Perrigo Company plc, Tolmar Pharmaceuticals, Inc., and Valeant Pharmaceuticals International, Inc.

Global Actinic Keratosis Market: Taxonomy

By Treatment Type

⚫ Topical treatment

1. 5-fluorouracil (5-FU) Cream
2. Imiquimod Cream
3. Diclofenac sodium gel
4. Ingenol mebutate gel
5. Others

⚫ Surgical Procedures

1. Cryosurgery
2. Curettage or Scrapping
3. Electrocautery
4. Laser Surgery
5. Others

⚫Photodynamic Therapy

By End User

⚪ Hospitals
⚪ Dermatologist Clinics
⚪ Oncology Centers
⚪ Ambulatory Surgical Centers

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐨 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐥𝐚𝐭 𝟑𝟎% 𝐎𝐅𝐅

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/insight/buy-now/1006

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Mr. Shah
Coherent Market Insights Pvt. Ltd.
+1 206-701-6702
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.